Dopa decarboxylase inhibitor compositions
AssigneeNeuroDerm, Ltd.
InventorOron Yacoby-Zeevi
Life of this patent
Estimating the term…
Abstract
Disclosed herein are formulations containing carbidopa and optionally levodopa, arginine, and other components that have reduced levels of impurities and toxins, particularly degradation productions. Also disclosed herein are methods of treatment diseases or conditions relating to a loss of dopamine or dopaminergic neurons using such formulations, methods of making such formulations, and kits that include such formulations.
Claims31
A pharmaceutically acceptable formulation comprising:
- (i) levodopa, about 0.1% to about 6% by weight carbidopa, about 1% to about 25% by weight of a component selected from the group consisting of arginine, meglumine, and a combination thereof, and at least one o-quinone scavenger;
- or
- (ii) about 8% to about 16% by weight levodopa, about 1% to about 4% by weight carbidopa, about 0.1% to about 40% by weight of a component selected from arginine, meglumine, and a combination thereof, and at least one o-quinone scavenger,
- wherein the pharmaceutically acceptable formulation has less than about 1 μg/ml of hydrazine, as determined by a gas chromatography-mass spectrometry (GCMS) method.
-11. (canceled)
A pharmaceutically acceptable formulation comprising:
- (a) carbidopa;
- (b) ascorbic acid or a salt thereof;
- and
- (c) one of L-cysteine, NAC, glutathione, and diacetylcystine, or a salt thereof, wherein said formulation has less than about 1 μg/ml of hydrazine, as determined by a GCMS method.
(canceled)
-17. (canceled)
(canceled)
-26. (canceled)
-31. (canceled)
-34. (canceled)
-50. (canceled)
-77. (canceled)
(canceled)
A method of reducing the impurities in a formulation containing levodopa and carbidopa, said method comprising:
- (a) mixing together levodopa and/or carbidopa, and a component selected from L-arginine or meglumine, and antioxidants;
- (b) add the mixture of step (a) into pre-heated water or bring the mixture at a temperature and for a time sufficient to dissolve the powders to form a solution;
- (c) cooling the solution to room temperature.
-90. (canceled)
Dependencies are inferred from the claim text.